Verastem VSTM
NASDAQ VSTM
$7.77 -0.13 (-1.63%)
As of: Oct 2, 2026 · 1:57 PM EDT

Verastem (VSTM) Non Operating Interest Expenses (2017 - 2026)

Updated

Verastem's Non Operating Interest Expenses was $360,000 in Q2 2026, up 69.8% from $212,000 a year earlier but down 5.8% from the prior quarter.

Analysis

Verastem (VSTM) Non Operating Interest Expenses (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Verastem's Non Operating Interest Expenses was $1.48 million through Jun 30, 2026, down 45.3% year-over-year; for FY2025, it came in at $1.14 million, down 75.1% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of -40.9% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $4.56 million in FY2024 (+10.2%), $4.14 million in FY2023 (+93.7%), $2.14 million in FY2022 (-78.6%) and $9.97 million in FY2021 (-36.9%).
  • Quarterly Non Operating Interest Expenses has moved between $10,000 (Q4 2021) and $7.98 million (Q3 2021) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in four of the last eight quarters, with an average decline of 16.0%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q3 2021 (growth of 320.4%); the worst was Q4 2021 (a decline of 99.3%).
  • Per Business Quant data, VSTM's Non Operating Interest Expenses in the three quarters before Q2 2026 was $382,000 (Q1 2026), $415,000 (Q4 2025) and $319,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Verastem 728.38 Mn 85.01 Mn 36.32 Mn 360,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 360,000.00
Mar 31, 2026 382,000.00
Dec 31, 2025 415,000.00
Sep 30, 2025 319,000.00
Jun 30, 2025 212,000.00
Mar 31, 2025 192,000.00
Dec 31, 2024 1.15 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 1.13 Mn
Dec 31, 2023 1.12 Mn
Sep 30, 2023 1.13 Mn
Jun 30, 2023 1.12 Mn
Mar 31, 2023 769,000.00
Dec 31, 2022 724,000.00
Sep 30, 2022 717,000.00
Jun 30, 2022 640,000.00
Mar 31, 2022 56,000.00
Dec 31, 2021 10,000.00
Sep 30, 2021 7.98 Mn
API Access

Verastem Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VSTM&period=max&api_key=YOUR_API_KEY